–Autonomize AI, a pioneer in AI-driven healthcare solutions, today announced that it raised $28 million in Series A funding, bringing total capital raised to $32 million to date. The round was led by Valtruis, The Cigna Group Ventures, Tau Ventures, and other strategic investors. Asset Management Ventures, ATX Venture Partners and Capital Factory are among the company’s existing investors who also participated.
The funding will be used to fuel the company’s mission to rewire healthcare operations with its Agentic AI Orchestration platform, enabling healthcare knowledge workers to focus on delivering better patient care by reducing the administrative burden that drives cost, clinician burnout, and fragmented experiences.
“The current healthcare system is no longer suited for the way care is delivered today—and too often, patients and clinicians pay the price in delayed treatment, wasted time, and unnecessary friction,” said Ganesh Padmanabhan, CEO of Autonomize AI. “Automation alone is not the answer for healthcare, but accountable, human-centered AI augmentation is. This funding will help us scale our platform to solve some of the most frustrating, high-impact operational challenges in healthcare, while keeping patients and care outcomes at the center.”
Autonomize AI stands apart with a platform purpose-built for the realities of healthcare. Its pre-trained, ready-to-deploy AI agents handle some of the industry’s most demanding workflows—like care management, utilization management, and benefits checks to chart reviews. These agents work together as intelligent Copilots in a coordinated, multi-agent system that understands real workflows, not just prompts. This isn’t generic Generative AI. It’s a healthcare-native orchestration platform already delivering real, measurable value at scale inside Fortune 100 healthcare enterprises.
“There’s never been a more important time to apply AI in healthcare,” said Mike Spadafore, Managing Director at Valtruis. “Healthcare operators are ready, but they need partners who understand real workflows and can deliver results at scale. That takes more than technical talent — it requires deep knowledge of how care is delivered and paid for. Autonomize AI gets that. Their platform enables healthcare operators to quickly deploy and scale AI agents across high-impact use cases — and they’re already driving real results at some of the country’s largest healthcare organizations. We’re excited for the opportunity to partner with them.”
Autonomize AI has already achieved transformative results, including:
- 36,000 clinical hours saved per month that was spent on mundane administrative tasks;
- 100,000+ automated care plans created monthly to free up care providers and case managers for higher-value patient interactions; and
- Up to 50% faster decisions for patients in prior authorizations and claims.
Unlike narrow solutions from generic AI platforms, Autonomize AI offers enterprise-wide orchestration and explainability to meet the complex needs of regulated healthcare environments with built-in transparency, human-in-the-loop workflows, and industry leading accuracy.
“Autonomize AI’s vision for augmenting, not replacing, the people who power healthcare is one we share,” said Craig Cimini, Head of The Cigna Group Ventures. “We see tremendous potential in the company’s platform to drive scalable, responsible innovation in healthcare operations while ensuring patients and providers remain at the center of care.”
Autonomize AI was founded in 2022 by Ganesh Padmanabhan and Kris Nair, with a goal to make healthcare more accessible, efficient and patient-centered with AI. The company is one of the few that has seen strong traction in multiple segments in healthcare and life sciences, delivering both patient impact and proven value at scale by solving real operational challenges.
About Autonomize AI
Autonomize’s AI copilots organize, contextualize and summarize unstructured data to reduce the administrative burden for healthcare knowledge workers to make data-driven decisions and improve patient outcomes. Their customers include Top 20 Pharmaceuticals, Fortune 100 Healthcare Enterprises, and Life Sciences companies.
Contacts
PR Contact
Avenue Z
autonomize@avenuez.com
